Huajian Zhu
Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities
Zhu, Huajian; Li, Wenlong; Shuai, Wen; Liu, Yang; Yang, Limei; Tan, Yuchen; Zheng, Tiandong; Yao, Hong; Xu, Jinyi; Zhu, Zheying; Yang, Dong-Hua; Chen, Zhe-Sheng; Xu, Shengtao
Authors
Wenlong Li
Wen Shuai
Yang Liu
Limei Yang
Yuchen Tan
Tiandong Zheng
Hong Yao
Jinyi Xu
Dr ZHEYING ZHU Zheying.Zhu@nottingham.ac.uk
ASSOCIATE PROFESSOR IN INTERNATIONAL PHARMACY AND TRADITIONAL MEDICINES
Dong-Hua Yang
Zhe-Sheng Chen
Shengtao Xu
Abstract
A series of novel N-benzylbenzamide derivatives were designed and synthesized as tubulin polymerization inhibitors. Among fifty-one target compounds, compound 20b exhibited significant antiproliferative activities with IC50 values ranging from 12 to 27 nM against several cancer cell lines, and possessed good plasma stability and satisfactory physicochemical properties. Mechanism studies demonstrated that 20b bound to the colchicine binding site and displayed potent anti-vascular activity. Notably, the corresponding disodium phosphate 20b-P exhibited an excellent safety profile with the LD50 value of 599.7 mg/kg (i.v. injection), meanwhile, it significantly inhibited tumor growth and decreased microvessel density in liver cancer cell H22 allograft mouse model without obvious toxicity. Collectively, 20b and 20b-P are novel promising anti-tubulin agents with more druggable properties and deserve to be further investigated for cancer therapy.
Citation
Zhu, H., Li, W., Shuai, W., Liu, Y., Yang, L., Tan, Y., Zheng, T., Yao, H., Xu, J., Zhu, Z., Yang, D.-H., Chen, Z.-S., & Xu, S. (2021). Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities. European Journal of Medicinal Chemistry, 216, Article 113316. https://doi.org/10.1016/j.ejmech.2021.113316
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 17, 2021 |
Online Publication Date | Feb 24, 2021 |
Publication Date | Apr 15, 2021 |
Deposit Date | Feb 27, 2021 |
Publicly Available Date | Feb 25, 2023 |
Journal | European Journal of Medicinal Chemistry |
Print ISSN | 0223-5234 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 216 |
Article Number | 113316 |
DOI | https://doi.org/10.1016/j.ejmech.2021.113316 |
Keywords | Organic Chemistry; Pharmacology; Drug Discovery; General Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/5353483 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S0223523421001653?via%3Dihub |
Files
EJMC Feb2021 - Tubulin - Accepted
(3.2 Mb)
PDF
You might also like
P102 Dissecting the metabolic impact of faecal microbiota transplantation (FMT) in C. difficile and E. coli infections using 3D OrbiSIMS
(2024)
Presentation / Conference Contribution
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search